Acute lymphoblastic leukemia and transplantation

Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

A treatment pathway, not one procedure

Acute lymphoblastic leukemia involves abnormal lymphoid precursor cells. Treatment is selected according to disease features and response, and may include chemotherapy, targeted treatment, immunotherapy and, for some patients, donor stem cell transplantation. The word transplant describes the restoration of blood-forming cells after preparative treatment; it does not mean that cells simply replace every leukemia cell.

Why timing matters

A transplant consultation may be appropriate in a high-risk situation or after recurrence, but it is not automatically the next step for everyone. Ask the leukemia team how response assessment and residual disease influence the recommendation. If another treatment is intended to achieve remission before transplant, clarify how that response will be measured and when reassessment occurs.

Children and adults need different services

Pediatric and adult ALL pathways are not interchangeable. A child should be evaluated by a pediatric hematology-oncology and transplant service with family support and developmentally appropriate consent processes. Adults may have different treatment tolerance, medical conditions and fertility priorities. International coordination should start with the appropriate specialist service rather than a general cosmetic or regenerative clinic.

Prepare a complete referral

Bring immunophenotyping, molecular testing, spinal fluid results when relevant, medication schedules and previous response assessments. Ask which records require translation and whether new tests would repeat work already completed. Discuss the anticipated duration near the hospital, caregiver requirements and a clear plan for urgent assessment if fever or new symptoms occur after discharge.

Continue exploring

• Acute myeloid leukemia and transplantation
• Multiple myeloma and autologous transplant
• Non-Hodgkin lymphoma and stem cell transplant
• Prepare your consultation checklist

Sources & further reading

• Primary patient information and research

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.